Prof. Elijah Behr, Consultant Cardiologist
Prof. Elijah Behr
Consultant Cardiologist
Prof. Behr is a Consultant Cardiologist
Mayo Clinic Q&A podcast: Heart rhythm problems need attention
Explore gallery
Prof. Behr is a Consultant Cardiologist with world recognised expertise in arrhythmias and genetics
Mayo Clinic Q&A podcast: Heart rhythm problems need attention
Areas of expertise
- Cardiology (heart health)
- Electrophysiology
- Arrhythmia
- Inherited cardiac conditions
- Cardiomyopathy
Make an appointment
Address
-
Mayo Clinic Healthcare
15 Portland Place, London, W1B 1PT
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
About Prof. Elijah Behr
GMC number: 4031491
Year qualified: 1993
Place of primary qualification: University of London
Prof. Elijah Behr is a distinguished expert in cardiology, specialising in the diagnosis, treatment, and management of arrhythmias. He holds the position of Professor of Cardiovascular Medicine at St George's University Hospital, where he leads pioneering research in arrhythmia. Additionally, he offers private consultations at Mayo Clinic Healthcare, Harley Street Clinic, and Surrey Cardiovascular Clinic.
Prof. Behr completed his primary medical education at the University of Cambridge and advanced cardiology training at St. George's Hospital. In 2007, he was appointed as a Consultant at St George's Hospital, where he heads the Inherited Cardiac Conditions and Arrhythmia Clinic. His leadership extends to his past role as President of the Association for Inherited Cardiac Conditions and his establishment of a focus group for the European Cardiac Arrhythmia Generics.
Beyond his clinical duties, Prof. Behr is an active contributor to the scientific community. He has authored numerous research papers in leading cardiology journals and serves on the editorial board of the Heart Rhythm Journal. His expertise is further recognised through his contributions to international guidelines on arrhythmia treatment and cardiac arrest. He is also involved in the UK 100,000 Genomes Project Cardiovascular Genome England Clinical Interpretation Partnerships.
Prof. Behr's clinical interests include the ablation of simple and complex arrhythmias, complex device therapy, and the management of sudden death risk. He treats conditions such as atrial fibrillation, Brugada syndrome, CPVT, cardiomyopathy, Sudden Arrhythmic Death Syndrome (SADS), and Sudden Infant Death Syndrome (SIDS).
Areas of expertise
- Ablation of arrhythmias
- Arrhythmia (irregular heartbeat)
- Arrhythmogenic cardiomyopathy
- Athlete's heart
- Atrial fibrillation
- Atrial flutter
- Bradycardia
- Brugada syndrome
- Cardiac ablation
- Cardiac arrest
- Cardiac generator replacement
- Cardiac pacing
- Cardiac resynchronisation therapy
- Cardiac screening
- Cardiac screening in sport
- Cardiology (heart health)
- Cardiomyopathy
- Cardiovascular genetics
- Cardioversion
- Catecholaminergic polymorphic ventricular tachycardia (CPVT)
- Catheter ablation
- Dilated cardiomyopathy
- ECG (electrocardiogram)
- ECG Holter monitor
- Echocardiogram
- Electrophysiology
- Exercise stress test
- Exercise testing
- Fainting
- Genetics
- Heart muscle disease
- Heart scan
- Hypertrophic cardiomyopathy
- ICD implantation
- Implantable cardioverter-defibrillator (ICD)
- Implantable loop recorder (ILR)
- Inherited cardiac conditions
- Long QT syndrome
- Loss of consciousness (syncope)
- Pacemaker implantation
- Pacemaker surgery
- Pacemakers
- Palpitations
- Sports cardiology
- Sudden arrhythmic death syndrome (SADS)
- Sudden death
- Supraventricular tachycardia (SVT)
- Tachycardia
- Transoesophageal echocardiogram
- Ventricular fibrillation
- Ventricular fibrillation and pulseless ventricular tachycardia (VF/VT)
Professional memberships
Articles by Prof. Elijah Behr
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Brugada Syndrome
RS/EHRA/APHRS expert consensus statement on the diagnosis & management of patients with inherited primary arrhythmia syndromes
Pharmacological treatment of acquired QT prolongation and torsades de pointes
Clinical management of Brugada Syndrome: commentary from the experts
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death
Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families
Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome
The diagnostic yield of Brugada Syndrome after sudden death with normal autopsy
Fibrosis, Connexin-43, and conduction abnormalities in the Brugada Syndrome
Biventricular myocardial fibrosis and sudden death in patients with Brugada Syndrome
Potential diagnostic role for a combined postmortem DNA anD RNA sequencing for Brugada Syndrome
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases
SCN5A Mutation Type and a genetic risk score associate variably with brugada syndrome phenotype in scn5a families
International Cardiovascular Research Partnership Awards
HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Application of artificial intelligence to the electrocardiogram
Information for the family and relatives of a young person who has died of Sudden Arrhythmic Death Syndrome – SADS sometimes called sudden adult death syndrome
Sudden arrhythmic death syndrome
